Close Menu

Published in Nature's early online edition, researchers at Children's Hospital Boston have used stem cells to study why cancer appears less in people with Down syndrome. Following up on previous studies, they found that one gene on chromosome 21, DSCR1, is increased in expression in Down's syndrome tissues and in a mouse model of Down's syndrome. DSCR1, Down's syndrome candidate region-1, encodes a protein that suppresses angiogenesis by the calcineurin pathway.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

An analysis of blood donations suggests SARS-CoV-2 was present in the US weeks earlier than thought, according to NPR.

The Guardian reports that DeepMind Technologies' AlphaFold can predict how proteins fold.

CNBC reports that a US Centers for Disease Control and Prevention advisory panel is to vote on how to distribute COVID-19 vaccines.

In PNAS this week: targeting progesterone signaling in ovarian cancer, LINE-1 retrotransposition events in adenocarcinomas, and more.